£1.9bn fraud fine for Glaxo in US sparks calls for UK prosecution
GlaxoSmithKline was last night facing calls to be prosecuted in Britain after the drugmaking giant pleaded guilty to criminal charges and paid a $3bn (£1.9bn) fine to settle what US government officials called the largest case of healthcare fraud in American history.
Brentford-based Glaxo targeted patients under the age of 18 with the antidepressant Paxil when it was only approved for adults, and pushed the drug Wellbutrin for uses for which it was not approved. These included weight loss and treatment of sexual dysfunction, according to an investigation by the US Justice Department.
The pharma giant should be punished in its home country too, according to Paul Flynn, the Labour MP who was Neil Kinnock's health spokesman.
He said: "GlaxoSmithKline has been involved in the same mis-selling here in the UK as has been found in the US. A major British drug company has been found bribing doctors, placing misleading articles in medical journals.
"These are huge offences. There have surely been many avoidable deaths as a result of its actions. We're too permissive of our control of pharmaceutical bodies in the UK. GlaxoSmithKline should be prosecuted here."
US authorities said Glaxo went to huge lengths to promote its drugs, including distributing a misleading medical journal article and providing doctors with meals and spa treatments that were classed as illegal kickbacks. The activities began in the late 1990s, and in some instances continued until 2007. Glaxo's agreement to plead guilty to three criminal counts is highly unusual.
The settlement includes $1bn in criminal fines and $2bn in civil fines. Glaxo chief executive Andrew Witty said the misconduct originated "in a different era for the company". In response to calls for a UK prosecution, the firm said:
A Glaxo spokesman said: "This settlement relates specifically to sales and marketing practices in the US and matters that occurred almost a decade ago. However, we acknowledge and regret what happened and have learnt from our mistakes.
"Since Andrew Witty became CEO in 2008, GSK has made significant changes at all levels within the company to ensure we act with integrity in everything we do, and these matters do not reflect the company that we are today."
elephant appealPrince William signs up for our charity appeal
elephant appealSo says man jailed for cutting off dead elephant's tusks
booksWe examine the best titles for teens
scienceResearchers teach border collie to understand sentences using more than 1,000 words
booksA Christmas story in six parts
travelWill high-value tourism help the workshops of this Renaissance city?
Geoffrey Macnab does not like the comedian's big screen debut
Top PR exec Justine Sacco under fire for sending racist tweet before flying to Africa
French pub fined €9,000 after customers returned empties to bar - because it's 'undeclared labour'
Ten best places to live in the UK: Hart in Hampshire takes top spot
'Untrue statements' anger over work to make H5N1 bird-flu virus MORE dangerous to humans
Paul Walker's daughter Meadow attends Justin Bieber Believe premiere
- 1 Top PR exec Justine Sacco under fire for sending racist tweet before flying to Africa
- 2 French pub fined €9,000 after customers returned empties to bar - because it's 'undeclared labour'
- 3 Sun will 'flip upside down' within weeks, says Nasa
- 4 The publisher who played with fire: the battle for control of Larsson's £30m legacy
- 5 Police seize possessions of rough sleepers in crackdown on homelessness
- < Previous
- Next >
iJobs Money & Business
£59999 - £80001 per annum + Benefits: Pro-Recruitment Group: A Top 10 firm in ...
£50000 - £75000 per annum + benefits + bonus: Harrington Starr: Project Manage...
£60000 - £90000 per annum + benefits + bonus: Harrington Starr: Business Analy...
£Negotiable: Citifocus: High calibre individual with institutional client serv...